Stem cell therapies are drastically changing today’s available options for surgery, medication, and physical therapy. With more research, access, and consistent communication, more lives can be changed for the better.
Medical professionals have a vast array of options at their disposal when it comes to medicine, treatments, and therapies thanks to research and case studies done over the years, but there is still more work to be done. Many experienced medical professionals champion stem cells as the next stage of evolution in medical care, and we couldn’t agree more.
An organization established in 2013 under the name Camden RAD, LLC, today known as Stem Cell Innovations (SCI) www.scia.io, has assumed a critical job in stem cell innovative work around the globe and has led its very own residential and global contextual analyses to facilitate the research in this field. SCI’s activities have specifically added to advancements in the field, and additionally to new stem cell discoveries around the globe. To finance a research and make stem cell treatments generally accessible, SCI has chosen to join stem cell research with another innovation – the blockchain technology.
But First, What Are Stem Cells?
Stem cells have the ability to regenerate, repair, and replenish other cells, which provides hope for the possibility of replacing diseased cells. One of the richest sources of stem cells is found in the umbilical cord and the placenta after a baby is delivered.
To date, four types of stem cells have been identified as being able to provide stem cell-related treatments and therapies. These types include embryonic stem cells, tissue-specified adult stem cells, mesenchymal synthetic stem cells, and induced pluripotent stem cells.
Of all the four cell types, embryonic stem cells are the purest form of stem cell. They are extracted from embryos and stored until needed. Embryonic stem cells can form into 220 known different cell types, providing the opportunity for a broad range of applications. Tissue-specified adult stem cells are limited in their application in medical treatments, and more information is needed about potential applications in the future.
Stem Cell Banking
One of the richest sources of stem cells is found on cord blood. Cord blood is found in the umbilical cord and placenta after a baby is delivered. The cells in this type of blood boost the immunity of both the mother and baby in preparation for labor. Being able to collect and store that blood for future use is a growing trend in medicine. Cord blood banking (also known as stem cell banking) is the process of collecting the cord blood and cryogenically freezing its stem cells.
Stem cell banking allows parents to safeguard their children against possible medical issues in the future by ensuring they have access to their own pure stem cells if needed. However, the complexity and cost of the current stem cell banking options present many barriers to parents who wish to take advantage of this medical technology. In addition to furthering research, SCI plans to offer stem cell banking through its stem cell application ecosystem. Parents will be able to order a collection kit, schedule courier pickup, and sign up for stem cell storage, all through one secure application. Because SCI will offer a worldwide network of stem cell storage and therapy options to its users, it is uniquely positioned to streamline the process of stem cell banking for parents and lower the costs for collection and storage.
Currently, hospitals and organizations in the United States and around the world are conducting stem cell research to further the field. To date, the majority of case studies reveal positive findings. During clinical research outside of the United States, stem cells have been used as a form of treatment successfully. Stem cell treatment and technology continues to be on the cutting edge of medical research and discovery, and we predict that stem cells will become an even more important part of the medical community. Breakthroughs in stem cell research span the gamut. The most successful and established stem cell therapies have been conducted with bone marrow transplants, which were first performed over 40 years ago thanks to researchers at Johns Hopkins University and their contributions.
Since then, further developments in bone marrow transplants have been made and are well documented in “Half-Matched Transplants,” and “Human Stem Cells at Johns Hopkins: A Forty Year History”.
For more information about SCI and the ICO, visit www.scia.io